FMC Stock Analysis — FMC Corporation
Sector: Chemicals
AI Verdict
FMC trades at 8.7x next year's earnings—cheap by any standard, but the market is signaling real skepticism that its patent moat can offset a -18.3% revenue slide.
Competitive Moat
FMC specializes in crop protection chemicals, with a defensible position built on proprietary active ingredients and a global distribution network that makes it hard for smaller rivals to compete at scale. Its patent portfolio and regulatory expertise create barriers to entry, especially in regulated markets.
Summary
FMC's forward P/E of 8.7x stands out for its deep discount as the company faces a sharp -18.3% revenue decline.
Where It Stands
FMC trades at just 8.7x next year's earnings, far below the chemicals sector norm, but this comes after a -18.3% revenue drop that signals real business pressure.
Key Metrics
- Forward P/E: 8.7x
- Revenue Growth: -0.2%
- Dividend Yield: 0.02%
- 52-Week High: $44.78
- 52-Week Low: $12.17
Analyst Consensus
8 Buy · 14 Hold · 2 Sell (24 analysts)
Bull Case
At 8.7x forward earnings, the stock is priced for pessimism, so any stabilization in revenue could drive a sharp rerating.
Bear Case
If the -18.3% revenue decline continues, even a low P/E could compress further, erasing another 20–30% if sentiment worsens.
Catalyst to Watch
Watch for quarterly updates on crop protection demand—any sign of revenue stabilization or return to growth could shift the narrative quickly.